Director, Knight Cancer Institute at Oregon Health & Science University; The JELD-WEN Chair of Leukemia Research, OHSU; Investigator at the Howard Hughes Medical Institute
We are facing a disturbing paradox in science. We have unprecedented potential for advancements spurred by current technologies. But at the same time we are confronting flat to declining funding.